0001209191-21-041617.txt : 20210617 0001209191-21-041617.hdr.sgml : 20210617 20210617175730 ACCESSION NUMBER: 0001209191-21-041617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenton Mary Kay CENTRAL INDEX KEY: 0001378589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39575 FILM NUMBER: 211026161 MAIL ADDRESS: STREET 1: ACHILLION PHARMACEUTICALS STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncorus, Inc. CENTRAL INDEX KEY: 0001671818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473779757 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-16 0 0001671818 Oncorus, Inc. ONCR 0001378589 Fenton Mary Kay C/O ONCORUS, INC. 50 HAMPSHIRE STREET, SUITE 401 CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 16.55 2021-06-16 4 A 0 12500 0.00 A 2031-06-15 Common Stock 12500 12500 D The option shall vest in 12 equal monthly installments commencing on July 16, 2021, subject to the Reporting Person continuing to provide service through each such date. /s/ Jason Minio, Attorney-in-Fact 2021-06-17